Mahdi Barzegar1,2,3,4, Omid Mirmosayyeb1,2,3,4, Nasim Nehzat1,2,3,4, Reza Sarrafi1,2,3,4, Farzin Khorvash1,2,3,4, Amir‐Hadi Maghzi1,2,3,4, Vahid Shaygannejad1,2,3,4
1Acquired Immunodeficiency Research Center (F.K.), Isfahan University of Medical Sciences, Iran
2From the Department of Neurology (M.B., O.M., R.S., V.S.), School of Medicine, Isfahan University of Medical Sciences
3From the Department of Neurology (M.B., O.M., R.S., V.S.), School of Medicine, Isfahan University of Medical Sciences; Isfahan Neurosciences Research Center (M.B., O.M., N.N., V.S.), Isfahan University of Medical Sciences; Acquired Immunodeficiency Research Center (F.K.), Isfahan University of Medical Sciences, Iran; and Ann Romney Center for Neurologic Diseases (A.-H.M.), Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
4Isfahan Neurosciences Research Center (M.B., O.M., N.N., V.S.), Isfahan University of Medical Sciences
